Updated:
Blythedale Children's Hospital
Blythedale Children's Hospital, located on a 95-acre campus in Valhalla, New York, operates as a nonprofit specialty hospital serving children with complex...
Blythedale Children's Hospital
Blythedale Children's Hospital, located on a 95-acre campus in Valhalla, New York, operates as a nonprofit specialty hospital serving children with complex medical needs, traumatic brain injuries, and chronic conditions requiring extended inpatient rehabilitation. Its associated foundation and board of trustees manage the institution's financial assets, including endowment funds, a beneficial interest in trust, and the hospital's physical plant, which features the Steven and Alexandra Cohen Pediatric Long Term Care Pavilion. Nathaniel Beers, MD serves as President and CEO, with John Canning, MPA as Executive Vice President and CFO. The investment committee allocates capital across a venture capital-heavy strategy alongside traditional asset classes. While the exact portfolio composition remains private, the committee's leadership structure points to a direct-investing posture. Perry C. Hoffmeister, Chairman of the Investment Committee, is concurrently a professional at Colter Lewis Investment Partners, an independent investment consulting and advisory firm. Trustee Asif Zaman is a Partner and Head of Healthcare Services at PPC Enterprises, a middle-market private equity firm. These relationships suggest a board capable of sourcing and diligencing healthcare-adjacent private investments directly rather than relying solely on fund-of-funds structures. The hospital benefits from multi-layered philanthropic partnerships that supplement its endowment capital. BTIG, the global financial services firm, has designated Blythedale as a long-term beneficiary of its annual BTIG Charity Day, which directs trading commissions to children's charities. Colbeck Capital Management, a private credit and special situations manager, supports the hospital's Wish List Fund. The Burke Neurological Institute collaborates with Blythedale on research into neurological impairment treatments. Collectively, these corporate and research partnerships provide both operating capital and reputational reinforcement beyond what the endowment alone supports. Blythedale's investment governance is shaped by a trustee committee where practicing investment professionals hold key roles — a structure more common among large university endowments than regional nonprofit hospitals. Hoffmeister and Zaman bring current, frontline asset-management and private-equity experience to committee decisions, reducing reliance on a single outsourced CIO or consultant model. This gives the foundation a structural capacity to underwrite direct co-investments alongside external managers, particularly in healthcare and venture, that smaller institutions without professionalized investment committees typically cannot replicate.
General information
Firm type
Endowment / Foundation
Year founded
1891
AUM
$160M–$165M (Altss estimate)
Location
Region
North America
Country
United States
City
Valhalla
Corporate office
95 Bradhurst Avenue, Valhalla, NY 10595, United States
Principals
Perry C. Hoffmeister
Trustee and Chairman of the Investment Committee
Asif Zaman
Trustee
Nathaniel Beers, MD
President and Chief Executive Officer
John Canning, MPA
Executive Vice President and Chief Financial Officer
Sector focus
Frequently asked questions
Who runs investment decisions at Blythedale Children's Hospital?
The investment committee of the board of trustees governs the endowment. Perry C. Hoffmeister serves as Chairman of the Investment Committee and is also a professional at Colter Lewis Investment Partners, an advisory firm. Trustee Asif Zaman, a Partner at private-equity firm PPC Enterprises, provides additional investment expertise. Day-to-day financial operations fall under John Canning, MPA, the hospital's Executive Vice President and CFO.
How is Blythedale's investment committee structured relative to a typical nonprofit hospital?
Blythedale seats practicing investment professionals directly on its investment committee — Hoffmeister from an institutional advisory firm and Zaman from a middle-market private-equity firm. Most regional nonprofit hospitals outsource investment management to a consultant or a single OCIO. Blythedale's structure allows the committee to evaluate direct co-investments and manager selections with insider diligence, giving it a posture closer to a small endowment office.
What is Blythedale Children's Hospital's investment strategy?
The foundation allocates heavily to venture capital, alongside traditional asset classes, based on Altss research. The committee's membership — healthcare services private equity (Zaman) and advisory (Hoffmeister) — suggests a sector-aware strategy. Specific portfolio holdings are not publicly disclosed, but the venture capital focus likely includes healthcare, technology, and therapeutics investments that align with the hospital's clinical mission.
What philanthropic partnerships support Blythedale beyond the endowment?
BTIG, the financial services firm, annually directs trading-commission proceeds to Blythedale through its BTIG Charity Day program. Colbeck Capital Management supports the hospital's Wish List Fund. The Burke Neurological Institute collaborates on neurological research. These partnerships provide operating capital, research funding, and reputational connectivity that augment the investment portfolio.
Who benefits from Blythedale's investment returns?
Investment returns support Blythedale's sole mission: providing inpatient and outpatient care for children with complex medical conditions, traumatic brain injuries, and chronic illnesses requiring extended rehabilitation. As New York's only specialty children's hospital focused on these populations, the endowment funds clinical operations, capital projects like the Cohen Pediatric Pavilion, and potentially uncompensated care.
Does Blythedale invest in healthcare-adjacent private equity or venture as a strategic LP?
While specific GP commitments are not publicly disclosed, the presence of a private-equity healthcare services partner (Zaman) on the investment committee makes sector-aligned fund commitments and direct co-investments plausible. The committee's composition is structured to evaluate healthcare private-equity and venture opportunities more rigorously than a generalist board could.
What is the relationship between Blythedale's campus real estate and its investment portfolio?
The hospital's endowment and the 95 Bradhurst Avenue campus, including the Cohen Pavilion, are distinct but managed under the same board fiduciary umbrella. The campus represents a fixed operating asset, while the endowment and beneficial interest in trust are liquid and semi-liquid pools deployed through the investment committee's venture-heavy strategy. They serve different purposes — the campus houses patients; the portfolio generates investment income.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on endowments & foundations?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: